First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
Titel:
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
Auteur:
Eichhorst, Barbara Fink, Anna-Maria Bahlo, Jasmin Busch, Raymonde Kovacs, Gabor Maurer, Christian Lange, Elisabeth Köppler, Hubert Kiehl, Michael Sökler, Martin Schlag, Rudolf Vehling-Kaiser, Ursula Köchling, Georg Plöger, Christoph Gregor, Michael Plesner, Torben Trneny, Marek Fischer, Kirsten Döhner, Harmut Kneba, Michael Wendtner, Clemens-Martin Klapper, Wolfram Kreuzer, Karl-Anton Stilgenbauer, Stephan Böttcher, Sebastian Hallek, Michael